Related references
Note: Only part of the references are listed.The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man
Naomi L. Sharma et al.
CANCER CELL (2013)
FoxA1 Specifies Unique Androgen and Glucocorticoid Receptor Binding Events in Prostate Cancer Cells
Biswajyoti Sahu et al.
CANCER RESEARCH (2013)
Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
Yingming Li et al.
CANCER RESEARCH (2013)
Androgen Receptor-Independent Function of FoxA1 in Prostate Cancer Metastasis
Hong-Jian Jin et al.
CANCER RESEARCH (2013)
Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity
Himisha Beltran et al.
EUROPEAN UROLOGY (2013)
FOXA1 Promotes Tumor Progression in Prostate Cancer and Represents a Novel Hallmark of Castration-Resistant Prostate Cancer
Josefine Gerhardt et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer
Mark Jesus M. Magbanua et al.
BMC CANCER (2012)
Common Structural and Epigenetic Changes in the Genome of Castration-Resistant Prostate Cancer
Terence W. Friedlander et al.
CANCER RESEARCH (2012)
Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model
Nicolas Floc'h et al.
CANCER RESEARCH (2012)
Distinct Patterns of Dysregulated Expression of Enzymes Involved in Androgen Synthesis and Metabolism in Metastatic Prostate Cancer Tumors
Nicholas Mitsiades et al.
CANCER RESEARCH (2012)
Androgen deprivation causes truncation of the C-terminal region of androgen receptor in human prostate cancer LNCaP cells
Naoki Harada et al.
CANCER SCIENCE (2012)
Modeling a Lethal Prostate Cancer Variant with Small-Cell Carcinoma Features
Vassiliki Tzelepi et al.
CLINICAL CANCER RESEARCH (2012)
Regulation of the androgen receptor by post-translational modifications
Kelly Coffey et al.
JOURNAL OF ENDOCRINOLOGY (2012)
Critical and Reciprocal Regulation of KLF4 and SLUG in Transforming Growth Factor β-Initiated Prostate Cancer Epithelial-Mesenchymal Transition
Yen-Nien Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Post-translational modification of the androgen receptor
Daniel Gioeli et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Karim Fizazi et al.
LANCET ONCOLOGY (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Christopher E. Barbieri et al.
NATURE GENETICS (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions
Keith F. Decker et al.
NUCLEIC ACIDS RESEARCH (2012)
AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression
Y. Li et al.
ONCOGENE (2012)
Modulators of Prostate Cancer Cell Proliferation and Viability Identified by Short-Hairpin RNA Library Screening
Kimberly Brown Dahlman et al.
PLOS ONE (2012)
Identification of Kinases Regulating Prostate Cancer Cell Growth Using an RNAi Phenotypic Screen
Hilary Whitworth et al.
PLOS ONE (2012)
Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth
David J. Mulholland et al.
CANCER CELL (2011)
Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
Brett S. Carver et al.
CANCER CELL (2011)
Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
Paivi Ostling et al.
CANCER RESEARCH (2011)
Small Molecule Inhibitors Targeting the Achilles' Heel of Androgen Receptor Activity
Marianne D. Sadar
CANCER RESEARCH (2011)
Definition of a FoxA1 Cistrome That Is Crucial for G1 to S-Phase Cell-Cycle Transit in Castration-Resistant Prostate Cancer
Chunpeng Zhang et al.
CANCER RESEARCH (2011)
Intragenic Rearrangement and Altered RNA Splicing of the Androgen Receptor in a Cell-Based Model of Prostate Cancer Progression
Yingming Li et al.
CANCER RESEARCH (2011)
Lupeol, a Novel Androgen Receptor Inhibitor: Implications in Prostate Cancer Therapy
Hifzur Rahman Siddique et al.
CLINICAL CANCER RESEARCH (2011)
Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants
Elahe A. Mostaghel et al.
CLINICAL CANCER RESEARCH (2011)
Alternatively spliced androgen receptor variants
Scott M. Dehm et al.
ENDOCRINE-RELATED CANCER (2011)
Testosterone dependent androgen receptor stabilization and activation of cell proliferation in primary human myometrial microvascular endothelial cells
Wolf Dietrich et al.
FERTILITY AND STERILITY (2011)
Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors
Christiane M. Robbins et al.
GENOME RESEARCH (2011)
High-level expression of forkhead-box protein A1 in metastatic prostate cancer
Rohit K. Jain et al.
HISTOPATHOLOGY (2011)
miR 488☆ inhibits androgen receptor expression in prostate carcinoma cells
Kavleen Sikand et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Regulation of Androgen Receptor and Prostate Cancer Growth by Cyclin-dependent Kinase 5
Fu-Ning Hsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target
Masaki Shiota et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2011)
Reduced Expression of the Androgen Receptor by Third Generation of Antisense Shows Antitumor Activity in Models of Prostate Cancer
Yixian Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Transcription Factor Stat5 Knockdown Enhances Androgen Receptor Degradation and Delays Castration-Resistant Prostate Cancer Progression In vivo
Christian Thomas et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases
Xiaotun Zhang et al.
PLOS ONE (2011)
A Snapshot of the Expression Signature of Androgen Receptor Splicing Variants and Their Distinctive Transcriptional Activities
Rong Hu et al.
PROSTATE (2011)
Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease
Michael J. Donovan et al.
BJU INTERNATIONAL (2010)
Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor
Raymond J. Andersen et al.
CANCER CELL (2010)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Compensatory Upregulation of Tyrosine Kinase Etk/BMX in Response to Androgen Deprivation Promotes Castration-Resistant Growth of Prostate Cancer Cells
Bojie Dai et al.
CANCER RESEARCH (2010)
Identification of EP4 as a Potential Target for the Treatment of Castration-Resistant Prostate Cancer Using a Novel Xenograft Model
Naoki Terada et al.
CANCER RESEARCH (2010)
Identification of Novel Truncated Androgen Receptor (AR) Mutants Including Unreported Pre-mRNA Splicing Variants in the 22Rv1 Hormone-Refractory Prostate Cancer (PCa) Cell Line
Gemma Marcias et al.
HUMAN MUTATION (2010)
Activation of Rac1 Is Closely Related to Androgen-Independent Cell Proliferation of Prostate Cancer Cells Both in Vitro and in Vivo
Takashi Kobayashi et al.
MOLECULAR ENDOCRINOLOGY (2010)
Post-transcriptional regulation of androgen receptor mRNA by an ErbB3 binding protein 1 in prostate cancer
Hua Zhou et al.
NUCLEIC ACIDS RESEARCH (2010)
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
Philip A. Watson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Increased Expression of Androgen Receptor Sensitizes Prostate Cancer Cells to Low Levels of Androgens
Kati K. Waltering et al.
CANCER RESEARCH (2009)
Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard et al.
CANCER RESEARCH (2009)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
Zhiyong Guo et al.
CANCER RESEARCH (2009)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
Qianben Wang et al.
CELL (2009)
Fluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer
Margaret A. Leversha et al.
CLINICAL CANCER RESEARCH (2009)
Mechanisms of Prostate Cancer Cell Survival After Inhibition of AR Expression
Michael B. Cohen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
A luminal epithelial stem cell that is a cell of origin for prostate cancer
Xi Wang et al.
NATURE (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer
Jennifer A. Locke et al.
CANCER RESEARCH (2008)
Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
R. Bruce Montgomery et al.
CANCER RESEARCH (2008)
Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events
Caterina Nardella et al.
GENES & DEVELOPMENT (2008)
Sintokamides A to E, Chlorinated Peptides from the Sponge Dysidea sp that Inhibit Transactivation of the N-Terminus of the Androgen Receptor in Prostate Cancer Cells
Marianne D. Sadar et al.
ORGANIC LETTERS (2008)
Cellular changes in prostate cancer cells induced by intermittent androgen suppression
Sari Laitinen et al.
EUROPEAN UROLOGY (2007)
Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation
Nupam P. Mahajan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Stabilizing androgen receptor in mitosis inhibits prostate cancer proliferation
Donald J. Vander Griend et al.
CELL CYCLE (2007)
Androgen receptor amplification is associated with increased cell proliferation in prostate cancer
Kyllikki Haapala et al.
HUMAN PATHOLOGY (2007)
Androgen receptor coregulators and their involvement in the development and progression of prostate cancer
Renee Chmelar et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Androgen receptor decoy molecules block the growth of prostate cancer
Steven N. Quayle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Requirement of androgen-dependent activation of protein kinase Cζ for androgen-dependent cell proliferation in LNCaP cells and its roles in transition to androgen-independent cells
Takahiro Inoue et al.
MOLECULAR ENDOCRINOLOGY (2006)
Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression
Helen Cheng et al.
CANCER RESEARCH (2006)
Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1
Shaoyong Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Regulation of androgen receptor activity by tyrosine phosphorylation
Zhiyong Guo et al.
CANCER CELL (2006)
Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes
Kazuki Yamanaka et al.
BJU INTERNATIONAL (2006)
Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer
M Stanbrough et al.
CANCER RESEARCH (2006)
The human PC346 xenograft and cell line panel: A model system for prostate cancer progression
RB Marques et al.
EUROPEAN UROLOGY (2006)
Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis
HI Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient
T Yoshida et al.
CANCER RESEARCH (2005)
Post-transcriptional regulation of the androgen receptor by mammalian target of rapamycin
B Cinar et al.
CANCER RESEARCH (2005)
Expression of androgen receptor coregulators in prostate cancer
MJ Linja et al.
CLINICAL CANCER RESEARCH (2004)
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer
HI Scher et al.
ENDOCRINE-RELATED CANCER (2004)
Molecular analysis integrating different pathways associated with androgen-independent progression in LuCaP 23.1 xenograft
P Rocchi et al.
ONCOGENE (2004)
Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
J Holzbeierlein et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Alterations of androgen receptor in prostate cancer
MJ Linja et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
DP Petrylak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Suppression versus induction of androgen receptor functions by the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells with different passage numbers
HK Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Androgen receptor gene amplification and protein expression in recurrent prostate cancer
OH Ford et al.
JOURNAL OF UROLOGY (2003)
Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer
J Edwards et al.
BRITISH JOURNAL OF CANCER (2003)
TRAIL-DISC formation is androgen-dependent in the human prostatic carcinoma cell line LNCaP
OW Rokhlin et al.
CANCER BIOLOGY & THERAPY (2002)
Novel binding of HuR and poly(C)-binding protein to a conserved UC-rich motif within the 3′-untranslated region of the androgen receptor messenger RNA
BB Yeap et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Stabilization of androgen receptor protein is induced by agonist, not by antagonists
T Furutani et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy
LV July et al.
PROSTATE (2002)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)
Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer
C Palmberg et al.
JOURNAL OF UROLOGY (2000)
Steroid-induced androgen receptor-oestradiol receptor β-Src complex triggers prostate cancer cell proliferation
A Migliaccio et al.
EMBO JOURNAL (2000)
FISH analysis of gene aberrations (MYC, CCND1, ERBB2, RB, and AR) in advanced prostatic carcinomas before and after androgen deprivation therapy
C Kaltz-Wittmer et al.
LABORATORY INVESTIGATION (2000)
Share Paper
